Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12955-014-0104-5.pdf
Reference40 articles.
1. Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS: Castration-resistant prostate cancer: AUA guideline. J Urol 2013, 190: 429–438. 10.1016/j.juro.2013.05.005
2. El-Amm J, Freeman A, Patel N, Aragon-Ching JB: Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigms. Prostate Cancer 2013, 2013: 210686. 10.1155/2013/210686
3. Scher HI, Morris MJ, Basch E, Heller G: End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice. J Clin Oncol 2011, 29: 3695–3704. 10.1200/JCO.2011.35.8648
4. Sternberg CN, Molina A, North S, Mainwaring P, Fizazi K, Hao Y, Rothman M, Gagnon DD, Kheoh T, Haqq CM, Cleeland C, de Bono JS, Scher HI: Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy. Ann Oncol 2013, 24: 1017–1025. 10.1093/annonc/mds585
5. Colloca G, Colloca P: Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need? Med Oncol 2011, 28: 519–527. 10.1007/s12032-010-9495-2
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews;Frontiers in Oncology;2023-09-27
2. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells;Gene;2023-05
3. A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology;Cancers;2022-10-19
4. Patient-reported outcome measures in vitreoretinal surgery: a systematic review;Eye;2022-05-12
5. Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment;Acta Oncologica;2021-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3